A detailed history of Invesco Ltd. transactions in Assertio Holdings, Inc. stock. As of the latest transaction made, Invesco Ltd. holds 756,206 shares of ASRT stock, worth $937,695. This represents 0.0% of its overall portfolio holdings.

Number of Shares
756,206
Previous 105,856 614.37%
Holding current value
$937,695
Previous $113,000 541.59%
% of portfolio
0.0%
Previous 0.0%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 14, 2024

BUY
$0.79 - $1.14 $513,776 - $741,398
650,350 Added 614.37%
756,206 $725,000
Q4 2023

Feb 12, 2024

SELL
$1.02 - $2.57 $146,724 - $369,689
-143,848 Reduced 57.61%
105,856 $113,000
Q3 2023

Nov 13, 2023

BUY
$2.52 - $5.69 $390,922 - $882,678
155,128 Added 164.02%
249,704 $639,000
Q2 2023

Aug 11, 2023

SELL
$5.0 - $7.66 $6.07 Million - $9.3 Million
-1,214,269 Reduced 92.77%
94,576 $512,000
Q1 2023

May 12, 2023

BUY
$3.54 - $6.66 $3.81 Million - $7.17 Million
1,076,253 Added 462.72%
1,308,845 $8.34 Million
Q4 2022

Feb 13, 2023

BUY
$2.48 - $4.3 $43,261 - $75,009
17,444 Added 8.11%
232,592 $1 Million
Q3 2022

Nov 14, 2022

SELL
$2.13 - $4.0 $25,636 - $48,144
-12,036 Reduced 5.3%
215,148 $488,000
Q2 2022

Aug 15, 2022

BUY
$1.88 - $3.42 $83,122 - $151,211
44,214 Added 24.16%
227,184 $670,000
Q1 2022

May 16, 2022

BUY
$2.06 - $3.0 $147,967 - $215,487
71,829 Added 64.63%
182,970 $525,000
Q4 2021

Feb 14, 2022

SELL
$0.86 - $2.3 $6,192 - $16,560
-7,200 Reduced 6.08%
111,141 $242,000
Q3 2021

Nov 15, 2021

BUY
$0.89 - $1.55 $3,683 - $6,415
4,139 Added 3.62%
118,341 $107,000
Q2 2021

Aug 17, 2021

BUY
$1.48 - $2.88 $169,018 - $328,901
114,202 New
114,202 $178,000

Others Institutions Holding ASRT

About Assertio Holdings, Inc.


  • Ticker ASRT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 48,178,200
  • Market Cap $59.7M
  • Description
  • Assertio Holdings, Inc., a specialty pharmaceutical company, provides medicines in the areas of neurology, hospital, and pain and inflammation. Its pharmaceutical products include INDOCIN, an oral solution and a suppository form for the treatment of moderate to severe rheumatoid arthritis, including acute flares of chronic disease; ankylosing sp...
More about ASRT
Track This Portfolio

Track Invesco Ltd. Portfolio

Follow Invesco Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Invesco Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Invesco Ltd. with notifications on news.